Related Experiment Video
Updated: Jul 6, 2026
05:46
Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
Radical hysterectomy in the elderly.
Azamsadat Mousavi1, Mojgan Karimi Zarchi, Mitra Modares Gilani
1Gynecologic Oncology Department, Vali-e-Asr Hospital, Imam Khomeini Hospital Complex, Keshavarz Blvd,, Tehran 14914, Iran. azamsadat_mousavi@yahoo.com
World Journal of Surgical Oncology
|April 9, 2008
Summary
Radical hysterectomy is safe for cervical cancer patients over 60. This study found no difference in mortality or morbidity compared to younger patients, indicating safety in older populations.
Area of Science:
- Gynecologic Oncology
- Surgical Oncology
- Geriatric Surgery
Background:
- Increasing life expectancy and cervical cancer rates in Iran necessitate evaluating surgical safety in older patients.
- Investigating the efficacy and safety of radical surgery for cervical cancer in patients aged 60 and above is crucial.
Purpose of the Study:
- To determine the safety and effectiveness of Wertheim radical hysterectomy in patients aged 60 years and older with cervical cancer.
- To compare surgical outcomes between older (≥60 years) and younger (<60 years) cervical cancer patients.
Main Methods:
- A historical cohort study compared 22 patients (≥60 years) with 128 matched controls (<60 years) who underwent Wertheim hysterectomy (1999-2005).
- Analysis included preoperative comorbidities, postoperative hospital stay, morbidity, and mortality.
Main Results:
- No operative mortality was observed in either group.
- Morbidity rates (minor and major) were not statistically different between the older and younger cohorts.
- Older patients had significantly higher pre-existing comorbidities but similar postoperative outcomes.
Conclusions:
- Wertheim radical hysterectomy is a safe procedure for selected cervical cancer patients aged 60 and over.
- Outcomes regarding operative mortality and morbidity are comparable between older and younger patient cohorts.
